Jody Cain
Investor Relations, LHA
Replay available
Matinas Biopharma Holdings, Inc. (MTNB) Q1 2023 Earnings Call
Matinas Biopharma Holdings, Inc. (AMEX: MTNB) Q1 2023 earnings conference call, held 2023-05-10. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Terry Makowitz
Chief Development Officer
Jerry DeBoer
Chief Executive Officer
Dr. Terry Ferguson
Chief Medical Officer
Keith Kaczynski
Chief Financial Officer
Julian Harrison
Analyst, BTIG
Greg Alexander
Individual Investor
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Matinas Biopharma Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:04.872 Greetings and welcome to the Matinas Biopharma first quarter 2023 conference call and 00:00:04.872 -- 00:00:08.835 webcast. At this time, all participants are in listen-only mode. 00:00:08.835 -- 00:00:12.258 A brief question and answer session will follow the formal presentation. 00:00:12.258 -- 00:00:15.580 If anyone should require operator assistance during the conference, please press star 00:00:15.580 -- 00:00:20.103 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:20.103 -- 00:00:23.125 It is now my pleasure to introduce your host, Jody Kane. 00:00:23.125 -- 00:00:25.506 Thank you, Jody. You may begin. 00:00:25.506 -- 00:00:30.628 This is Jody Cain with LHA. Thank you for participating in today's call. 00:00:30.628 -- 00:00:36.170 Speaking on today's call from Matinas Biopharma will be Jerry DeBoer, Chief Executive 00:00:36.170 -- 00:00:40.792 Officer, Dr. Terry Makowitz, Chief Development Officer, Dr. 00:00:40.792 -- 00:00:46.675 Terry Ferguson, Chief Medical Officer, and Keith Kaczynski, Chief Financial Officer. 00:00:46.675 -- 00:00:51.577 I'd like to remind listeners that remarks made during this call may state management's 00:00:51.577 -- 00:00:56.565 future intentions hopes, beliefs, expectations, or projections. 00:00:56.565 -- 00:01:00.606 These are forward-looking statements and involve risks and uncertainties. 00:01:00.606 -- 00:01:05.028 Forward-looking statements are made pursuant to the safe harbor provisions of the federal 00:01:05.028 -- 00:01:10.049 securities laws. These forward-looking statements are based on Matinas Biopharma's 00:01:10.049 -- 00:01:15.171 current expectations and actual results could differ materially. 00:01:15.171 -- 00:01:20.882 As a result, you shou...